Microdissected metaplastic breast carcinoma has been shown to have a specific loss of miR-200 which correlates with increased expression of vimentin and decreased E-cadherin in the mesenchymal component [30], [31]. The gene discussed is CDH1; the disease is metaplastic breast carcinoma.